Naltrexone Enhanced Addiction Treatment (NEAT): A controlled study of the clinical and cost-effectiveness of extended-release naltrexone and oral naltrexone.
This study was terminated in the United Kingdom. It focuses on Addiction.
In United Kingdom
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study was terminated in the United Kingdom. It focuses on Addiction.
In United KingdomThis study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.
In New HavenThis summary needs review. Please check the official study record and contact the research team for details.
In DallasThis summary needs review. Please check the official study record and contact the research team for details.
In Los AngelesThis summary needs review. Please check the official study record and contact the research team for details.
In LimaThis study is completed in the United States. It focuses on Addiction.
Multiple locations, including OceansideThis summary needs review. Please check the official study record and contact the research team for details.
In OsloThis summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis summary needs review. Please check the official study record and contact the research team for details.
In OsloThis summary needs review. Please check the official study record and contact the research team for details.
In Kansas CityThis summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including National CityHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.